Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77714647 | 7771464 | 7 | F | 201102 | 20160629 | 20110124 | 20160706 | EXP | BR-PFIZER INC-2011011004 | PFIZER | 68.00 | YR | M | Y | 79.00000 | KG | 20160706 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77714647 | 7771464 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 50 MG, 2 TABLETS BEFORE SEXUAL INTERCOURSE | N | 20895 | 50 | MG | FILM-COATED TABLET | ||||||
| 77714647 | 7771464 | 2 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 50 MG, 1X/DAY | N | 20895 | 50 | MG | FILM-COATED TABLET | QD | |||||
| 77714647 | 7771464 | 3 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 2 TABLETS OF 50MG AT ONCE | N | 20895 | 100 | MG | FILM-COATED TABLET | ||||||
| 77714647 | 7771464 | 4 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 50 MG, UNK | N | 20895 | 50 | MG | FILM-COATED TABLET | ||||||
| 77714647 | 7771464 | 5 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 120 MG, BEFORE SEXUAL INTERCOUSE | N | 20895 | 120 | MG | FILM-COATED TABLET | ||||||
| 77714647 | 7771464 | 6 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, 1X/DAY | N | 20895 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 77714647 | 7771464 | 7 | SS | CIALIS | TADALAFIL | 1 | Oral | 2 TABLETS OF 20 MG | U | 0 | 40 | MG | |||||||
| 77714647 | 7771464 | 8 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD | ||||||||
| 77714647 | 7771464 | 9 | C | SELOZOK | METOPROLOL SUCCINATE | 1 | 12.5 MG, 2X/DAY | 0 | 12.5 | MG | BID | ||||||||
| 77714647 | 7771464 | 10 | C | LOSARTAN. | LOSARTAN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 77714647 | 7771464 | 1 | Erectile dysfunction |
| 77714647 | 7771464 | 7 | Erectile dysfunction |
| 77714647 | 7771464 | 8 | Thrombosis prophylaxis |
| 77714647 | 7771464 | 9 | Hypertension |
| 77714647 | 7771464 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 77714647 | 7771464 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 77714647 | 7771464 | Depression | |
| 77714647 | 7771464 | Drug ineffective | |
| 77714647 | 7771464 | Feeling of despair | |
| 77714647 | 7771464 | Frustration tolerance decreased | |
| 77714647 | 7771464 | Intentional product use issue | |
| 77714647 | 7771464 | Irritability | |
| 77714647 | 7771464 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 77714647 | 7771464 | 2 | 2003 | 0 | ||
| 77714647 | 7771464 | 4 | 20110110 | 0 | ||
| 77714647 | 7771464 | 9 | 1998 | 0 | ||
| 77714647 | 7771464 | 10 | 1998 | 0 |